IL17A and neoplasm: Alternatively, the tumour cells are also able to perpetuate the local inflammatory response through the expression of CC chemokine ligand 2 (CCL 2) which stimulates entry of IL-17 expressing monocytes which can contribute to the local inflammatory reaction [38].